Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms D-LIFT
- 17 Aug 2019 Planned End Date changed from 1 Sep 2020 to 1 Mar 2020.
- 17 Aug 2019 Planned primary completion date changed from 1 Jan 2020 to 1 Aug 2019.
- 17 Aug 2019 Status changed from recruiting to active, no longer recruiting.